)
Visual
earnings real time
Fresenius (FRE) investor relations material
Fresenius Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Status Update summary15 Dec, 2025
Strategic vision and market positioning
Focused on biopharma as a core growth vector, leveraging demographic trends, rising healthcare spending, and addressing global needs such as longevity and efficiency gaps.
Commitment to affordable, accessible, and innovative healthcare, aiming for market leadership in next-level therapies.
Biopharma business is positioned as a fully integrated, vertically aligned powerhouse with 11 marketed products and a robust pipeline.
Clear ambition to double biopharma revenue and portfolio by 2030, targeting a 20% EBIT margin.
Capital allocation is focused on in-house R&D, capacity expansion, and selective in-licensing, with over EUR 300 million planned investment by 2030.
Financial performance and guidance
Biopharma revenue surpassed EUR 800 million in 2025, exceeding 2026 targets, with sales growing over 30% at constant currency.
Achieved EBIT and EBITDA break-even ahead of schedule; EBIT margin improved from 8.5% (2022) to over 15% (first nine months 2025).
2030 ambition is to double revenue from today’s base and reach a 20% EBIT margin, driven by new launches and increased market share.
Revenue growth is underpinned by both existing and late-stage pipeline molecules, with a CAGR of around 15% through 2030.
Biopharma significantly contributes to EBIT growth, with margins rising from 8.5% in FY22 to 15.2% in Q1-3/25.
Portfolio, pipeline, and R&D strategy
Portfolio includes 11 marketed products across nine molecules, with plans to double the number of molecules by 2030.
Pipeline covers EUR 200 billion in originator sales, with 15 new medicines targeted and a mix of in-house and in-licensed assets.
Targeting 2+ new molecules entering development annually, leveraging in-house R&D and strategic in-licensing.
Demonstrated ability to launch first-to-market biosimilars and secure regulatory approvals, with eight FDA/BLA approvals between 2022-2025.
Strategic focus on immunology, oncology, and expansion into adjacent therapeutic areas.
How is denosumab biosimilar differentiated?
What is the target for DS internalization by 2030?
How do US access agreements drive volume?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Fresenius earnings date
Q4 202525 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Fresenius SE & Co. KGaA operates as a health care group that provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company offers infusion therapies and clinical nutrition products; medical devices and services comprising renal, hospital, and surgical products; dialysis services through a network of independent subsidiary Fresenius Medical Care clinics; assistance with the promotion of healthy lifestyles, disease prevention services, and homecare services; hospital management and care management as well as hospital construction planning and financing services; and consulting, engineering, environmental, healthcare infrastructure development, project logistics/supply chain management/product testing, rail vehicle maintenance/IT security infrastructure support/e-learning platform operations in Germany.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage